(Q34229030)

31 July 2017

1 reference

title

Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis (English)

1 reference

31 July 2017

author name string

M C Le Bousse-Kerdilès

series ordinal

1

1 reference

31 July 2017

M C Martyré

series ordinal

2

1 reference

31 July 2017

French INSERM research network on Idiopathic Myelofibrosis

series ordinal

3

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

published in

Pathology and Biology

1 reference

31 July 2017

volume

49

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

153-157

1 reference

Gd(-) Abrami a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Multilineage expression of haemopoietic precursors with an abnormal clone in idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

The fibroblast growth factor family: structural and biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

"Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: A trivial phenomenon or a novel secretion mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Effects of type beta transforming growth factors on haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

The role of transforming growth factor-beta in hematopoiesis. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

CD44 and hyaluronan binding by human myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF beta receptor subtype and decreases the growth inhibitory response to TGF-beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

Pathogenesis of idiopathic myelofibrosis: present status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2800%2900021-3

7 January 2021

10.1016/S0369-8114(00)00021-3

Identifiers

DOI

1 reference

31 July 2017

1 reference